Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne H Cross

Showing results (11-20 of 194) with videos related to

Pageof 20
Sort By:
Frontiers in Neurology|February 8, 2021
Anti-CD20 B Cell Treatment for Relapsing Multiple SclerosisCharles A Roach, Anne H Cross
Nature Reviews. Neurology|November 5, 2010
Multiple sclerosis: oligoclonal bands still yield clues about multiple sclerosisAnne H Cross, Gregory F Wu
The Journal of Clinical Investigation|February 3, 2007
A little stress is good: IFN-gamma, demyelination, and multiple sclerosisJason R Lees, Anne H Cross
Current Neurology and Neuroscience Reports|May 10, 2007
B cells: no longer the nondominant arm of multiple sclerosisEric C Klawiter, Anne H Cross
Archives of Neurology|November 16, 2005
Multiple sclerosis and black holes: connecting the pixelsRobert T Naismith, Anne H Cross
JAMA Neurology|January 1, 2016
Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral ImmunityErin E Longbrake, Anne H Cross
Immunologic Research|August 18, 2005
Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitisAnne H Cross, Jennifer L Stark
Neurology|August 9, 2013
Comment: assessing humoral immunocompetence after alemtuzumab treatment in MSAnne H Cross, Robyn S Klein
The Lancet. Neurology|July 16, 2022
Further support for rituximab in relapsing multiple sclerosisRobert T Naismith, Anne H Cross
Neurology|September 1, 2010
The four seasons of multiple sclerosisAnne H Cross, Becky Jo Parks
Pageof 20

Showing results (11-20 of 194) with videos related to

Sort By:
Pageof 20
Frontiers in Neurology|February 8, 2021
Anti-CD20 B Cell Treatment for Relapsing Multiple SclerosisCharles A Roach, Anne H Cross
Nature Reviews. Neurology|November 5, 2010
Multiple sclerosis: oligoclonal bands still yield clues about multiple sclerosisAnne H Cross, Gregory F Wu
The Journal of Clinical Investigation|February 3, 2007
A little stress is good: IFN-gamma, demyelination, and multiple sclerosisJason R Lees, Anne H Cross
Current Neurology and Neuroscience Reports|May 10, 2007
B cells: no longer the nondominant arm of multiple sclerosisEric C Klawiter, Anne H Cross
Archives of Neurology|November 16, 2005
Multiple sclerosis and black holes: connecting the pixelsRobert T Naismith, Anne H Cross
JAMA Neurology|January 1, 2016
Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral ImmunityErin E Longbrake, Anne H Cross
Immunologic Research|August 18, 2005
Humoral immunity in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitisAnne H Cross, Jennifer L Stark
Neurology|August 9, 2013
Comment: assessing humoral immunocompetence after alemtuzumab treatment in MSAnne H Cross, Robyn S Klein
The Lancet. Neurology|July 16, 2022
Further support for rituximab in relapsing multiple sclerosisRobert T Naismith, Anne H Cross
Neurology|September 1, 2010
The four seasons of multiple sclerosisAnne H Cross, Becky Jo Parks
Pageof 20